JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB89821

Anti-Perforin antibody [5B10]

Be the first to review this product! Submit a review

|

(8 Publications )

Anti-Perforin antibody [5B10] (ab89821) is a mouse monoclonal antibody detecting Perforin in IHC-P. Suitable for Human.

- Trusted since 2010
1 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Perforin antibody [5B10] (AB89821)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Perforin antibody [5B10] (AB89821)

Immunohistochemical analysis of human spleen labeling Perforin with ab89821 at 1 : 20 dilution. Secondary antibody was RTU PolyVue Plus HRP.

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

5B10

Isotype

IgG1

Carrier free

No

Reacts with

Human

Applications

IHC-P

applications

Immunogen

Recombinant Fragment Protein within Human PRF1. The exact immunogen used to generate this antibody is proprietary information.

P14222

Specificity

This antibody is specific to a 70 kDa protein, which is a potent cytolytic pore-forming protein.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/10 - 1/20", "IHCP-species-notes": "<p></p>" } } }

Product details

What is this antibody validated in?
Anti-Perforin antibody [5B10] (ab89821) is a mouse monoclonal antibody and is validated for use in Immunohistochemistry (IHC-P) in Human samples.

Properties and storage information

Form
Liquid
Purity
Tissue culture supernatant
Storage buffer
pH: 7.3 - 7.5 Preservative: 0.05% Sodium azide Constituents: 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Perforin also referred to as PRF1 is a pore-forming protein that plays an important role in immune response. It appears as a 67-kDa protein and is mainly expressed in cytotoxic T cells and natural killer (NK) cells. The function of perforin involves the formation of transmembrane pores in the membranes of target cells aiding in the delivery of pro-apoptotic molecules. This mechanism is essential for the destruction of virus-infected cells and tumor cells. Techniques like perforin IHC and perforin ELISA are suitable for detecting and quantifying this protein in various samples.
Biological function summary

Perforin helps the immune system respond effectively against infected or malignant cells. It works in conjunction with granzymes forming a complex that perforates target cell membranes allowing granzymes to enter and induce apoptosis. Perforin's role in immune surveillance prevents the propagation of harmful cells within the body. Deficiency or malfunction in perforin can lead to compromised immune function or immune cell dysregulation.

Pathways

Perforin integrates into the cytotoxic T lymphocyte (CTL) and NK cell-mediated cytotoxicity pathways. These pathways include critical interactions with proteins like granzymes and Fas ligand (FasL) which orchestrate the apoptosis of abnormal cells. Through these pathways perforin ensures the body's ability to identify and eliminate threats. The granule exocytosis pathway in particular heavily depends on perforin's activity to execute effective immune responses.

Mutations or defects in perforin are linked to familial hemophagocytic lymphohistiocytosis (FHL) and some types of cancer. These conditions arise when perforin's ability to function correctly is impaired. For instance in FHL defective perforin hampers the immune cells' ability to kill target cells leading to uncontrolled immune activation. Furthermore in the context of cancer the proper functioning of perforin alongside proteins like granzyme B is critical for the surveillance and elimination of tumor cells.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Pore-forming protein that plays a key role in granzyme-mediated programmed cell death, and in defense against virus-infected or neoplastic cells (PubMed : 20889983, PubMed : 21037563, PubMed : 24558045, PubMed : 9058810, PubMed : 9164947). Plays an important role in killing other cells that are recognized as non-self by the immune system, e.g. in transplant rejection or some forms of autoimmune disease (PubMed : 9058810). Can insert into the membrane of target cells in its calcium-bound form, oligomerize and form large pores (PubMed : 20889983, PubMed : 21037563). Promotes cytolysis and apoptosis of target cells by mediating the passage and uptake of cytotoxic granzymes (PubMed : 20038786, PubMed : 20225066, PubMed : 24558045, PubMed : 32299851). Facilitates the delivery of cationic cargo protein, while anionic or neural proteins are not delivered efficiently (PubMed : 24558045). Perforin pores allow the release of mature caspase-7 (CASP7) into the extracellular milieu (By similarity).
See full target information PRF1

Alternative Names

PFP, PRF1, Perforin-1, P1, Cytolysin, Lymphocyte pore-forming protein

Publications (8)

Recent publications for all applications. Explore the full listand refine your search

Cancer research communications 5:358-368 PubMed39895413

2025

Phase Ib Study of Immunocytokine Simlukafusp Alfa (FAP-IL2v) Combined with Pembrolizumab for Treatment of Advanced and/or Metastatic Melanoma.

Applications

Unspecified application

Species

Unspecified reactive species

Eva Munoz-Couselo,Ainara Soria Rivas,Shahneen Sandhu,Georgina V Long,Miguel F Sanmamed,Anna Spreafico,Elizabeth Buchbinder,Mario Sznol,Hans Prenen,Alexander Fedenko,Mohammed Milhem,Ana Maria Arance Fernandez,Jean-Jacques Grob,Lev Demidov,Caroline Robert,Christin Habigt,Stefan Evers,Nassim Sleiman,David Dejardin,Caroline Ardeshir,Nicole Martin,Christophe Boetsch,Jehad Charo,Volker Teichgräber,Anton Kraxner,Nino Keshelava,Oliver Bechter

Clinical cancer research : an official journal of the American Association for Cancer Research 30:5540-5547 PubMed39422604

2024

Phase Ib Study of the Immunocytokine Simlukafusp Alfa (FAP-IL2v) in Combination with Cetuximab in Patients with Head and Neck Squamous Cell Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Aaron R Hansen,Carlos A Gomez-Roca,Debbie G J Robbrecht,Loic Verlingue,Antoine Italiano,Julie E Bauman,Neeltje Steeghs,Hans Prenen,Jérôme Fayette,James Spicer,Jiaxin Niu,Christin Habigt,Meike Schneider,Stefan Evers,Nassim Sleiman,David Dejardin,Caroline Ardeshir,Daniela Schmid,Christophe Boetsch,Jehad Charo,Anton Kraxner,Volker Teichgräber,Nino Keshelava,Marcelo R Bonomi

Frontiers in immunology 15:1352632 PubMed39035007

2024

Investigating the complex interplay between fibroblast activation protein α-positive cancer associated fibroblasts and the tumor microenvironment in the context of cancer immunotherapy.

Applications

Unspecified application

Species

Unspecified reactive species

Anton Kraxner,Franziska Braun,Wei-Yi Cheng,Tai-Hsien Ou Yang,Shweta Pipaliya,Marta Canamero,Emilia Andersson,Suzana Vega Harring,Sebastian Dziadek,Ann-Marie E Bröske,Maurizio Ceppi,Tamara Tanos,Volker Teichgräber,Jehad Charo

Neurology(R) neuroimmunology & neuroinflammation 10: PubMed37080596

2023

Effects of a Small-Molecule Perforin Inhibitor in a Mouse Model of CD8 T Cell-Mediated Neuroinflammation.

Applications

Unspecified application

Species

Unspecified reactive species

Carmen Gonzalez-Fierro,Coralie Fonte,Eloïse Dufourd,Vincent Cazaentre,Sidar Aydin,Britta Engelhardt,Rachel R Caspi,Biying Xu,Guillaume Martin-Blondel,Julie A Spicer,Joseph A Trapani,Jan Bauer,Roland S Liblau,Chloé Bost

Cancer cell 40:1600-1618.e10 PubMed36423635

2022

Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1 T lymphocyte niches through a feed-forward loop.

Applications

Unspecified application

Species

Unspecified reactive species

Yichao Hua,Gerlanda Vella,Florian Rambow,Elizabeth Allen,Asier Antoranz Martinez,Marie Duhamel,Akira Takeda,Sirpa Jalkanen,Steffie Junius,Ann Smeets,David Nittner,Stefanie Dimmeler,Thomas Hehlgans,Adrian Liston,Francesca Maria Bosisio,Giuseppe Floris,Damya Laoui,Maija Hollmén,Diether Lambrechts,Pascal Merchiers,Jean-Christophe Marine,Susan Schlenner,Gabriele Bergers

JFMS open reports 5:2055116919863080 PubMed31321069

2019

Blastic natural killer cell lymphoma/leukaemia in a cat.

Applications

Unspecified application

Species

Unspecified reactive species

Miyuki Hirabayashi,James K Chambers,Mei Sugawara,Aki Ohmi,Hajime Tsujimoto,Hiroyuki Nakayama,Kazuyuki Uchida

Journal of immunology (Baltimore, Md. : 1950) 192:2120-32 PubMed24489088

2014

CD4+ T cells contain early extrapulmonary tuberculosis (TB) dissemination and rapid TB progression and sustain multieffector functions of CD8+ T and CD3- lymphocytes: mechanisms of CD4+ T cell immunity.

Applications

Unspecified application

Species

Unspecified reactive species

Shuyu Yao,Dan Huang,Crystal Y Chen,Lisa Halliday,Richard C Wang,Zheng W Chen

Cancer research 73:1892-9 PubMed23302230

2013

Focused ultrasound delivers targeted immune cells to metastatic brain tumors.

Applications

IHC-P

Species

Human

Ryan Alkins,Alison Burgess,Milan Ganguly,Giulio Francia,Robert Kerbel,Winfried S Wels,Kullervo Hynynen
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com